# Cardax Pharma (CDXI) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/CDXI
## Company Profile
- Ticker: CDXI
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
## Stock Data
- Close: 0.0001 USD
- Market cap: Not available USD
- Last updated: 2026-08-27
## Business Overview
Cardax was a specialty biopharmaceutical company focused on inflammation-related products and nutraceutical or therapeutic concepts. Its story was built around a narrow anti-inflammatory thesis.
## Why The Stock Is Moving

Current closing-price context is not available for CDXI.

## Geographic Base

Cardax is headquartered in the United States and listed on NASDAQ. It sits in specialty biopharma.

## Business Model

The company depended on commercial or development progress, capital management, and the ability to maintain a focused product set. Investors historically watched revenue and strategic repositioning.

## Landscape Position

Cardax belongs to the historical specialty-inflammation bucket. It is a small company where execution and survival mattered as much as the science.

## Future Catalysts

- Cardax is a legacy / closeout story, with catalysts limited to any strategic or asset-resolution update. There is no active standalone growth story left.

## Recent News
- 2023-12-06 20:00 EST — [Cardax Announces Breakthrough Longevity Results with ZanthoSyn® in NIH-Funded Study](https://biopharmsignal.com/news/CDXI/cardax-announces-breakthrough-longevity-results-with-zanthosynr-in-nih-funded-study) — Source: Cardax Pharma
- 2021-08-31 22:18 EST — [Cardax Refocuses on ZanthoSyn® Consumer Health Business](https://biopharmsignal.com/news/CDXI/cardax-refocuses-on-zanthosynr-consumer-health-business) — Source: Cardax Pharma
- 2021-08-11 21:00 EST — [Cardax Voluntarily Suspends SEC Reporting Obligations](https://biopharmsignal.com/news/CDXI/cardax-voluntarily-suspends-sec-reporting-obligations) — Source: Cardax Pharma
- 2021-05-14 12:00 EST — [Cardax Reports Q1 2021 Results](https://biopharmsignal.com/news/CDXI/cardax-reports-q1-2021-results) — Source: Cardax Pharma
- 2021-04-15 12:00 EST — [Cardax Reports 2020 Results](https://biopharmsignal.com/news/CDXI/cardax-reports-2020-results) — Source: Cardax Pharma
